Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Scholar Rock Holding Corporation(SRRK) | 5,612,896 | 6,897,652 | +1,284,756 | $209.02M | $303.84M | 31.35% | +$94.82M |
| Mineralys Therapeutics, Inc.(MLYS) | 6,263,151 | 5,871,018 | -392,133 | $237.50M | $213.06M | 21.98% | -$24.44M |
| Kalaris Therapeutics, Inc.(KLRS) | 11,448,081 | 12,948,081 | +1,500,000 | $66.17M | $109.28M | 11.27% | +$43.11M |
| Septerna, Inc.(SEPN) | 3,149,128 | 3,149,128 | 0 | $59.24M | $87.80M | 9.06% | +$28.56M |
| Alumis Inc | 4,801,370 | 5,756,984 | +955,614 | $19.16M | $56.19M | 5.80% | +$37.03M |
| Neurogene Inc.(NGNE) | 1,717,127 | 1,717,127 | 0 | $29.76M | $35.37M | 3.65% | +$5.62M |
| Inventiva S.A.ADS(IVA) | 0 | 5,194,805 | +5,194,805 | $0 | $24.16M | 2.49% | +$24.16M |
| Gossamer Bio, Inc.(GOSS) | 6,130,268 | 7,222,559 | +1,092,291 | $16.12M | $22.39M | 2.31% | +$6.27M |
| Upstream Bio, Inc.(UPB) | 962,154 | 736,047 | -226,107 | $18.10M | $19.98M | 2.06% | +$1.89M |
| Aquestive Therapeutics Inc | 2,500,000 | 2,500,000 | 0 | $13.97M | $16.15M | 1.67% | +$2.17M |
| Jade Biosciences Inc | 531,163 | 968,798 | +437,635 | $4.58M | $14.95M | 1.54% | +$10.36M |
| vTv Therapeutics Inc.CL A(VTVT) | 374,461 | 298,496 | -75,965 | $8.74M | $11.94M | 1.23% | +$3.19M |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 0 | 8,500,000 | +8,500,000 | $0 | $11.47M | 1.18% | +$11.47M |
| Palvella Therapeutics, Inc.(PVLA) | 209,634 | 104,817 | -104,817 | $13.14M | $10.97M | 1.13% | -$2.17M |
| ABIVAX Société AnonymeADS(ABVX) | 75,442 | 75,442 | 0 | $6.41M | $10.17M | 1.05% | +$3.77M |
| X4 Pharmaceuticals, Inc.(XFOR) | 0 | 1,960,000 | +1,960,000 | $0 | $7.84M | 0.81% | +$7.84M |
| Nkarta, Inc.(NKTX) | 3,768,035 | 3,507,666 | -260,369 | $7.80M | $6.49M | 0.67% | -$1.31M |
| Arcellx Inc COMMON STOCK | 81,165 | 60,873 | -20,292 | $6.66M | $3.97M | 0.41% | -$2.69M |
| Sutro Biopharma, Inc.(STRO) | 0 | 204,503 | +204,503 | $0 | $2.37M | 0.24% | +$2.37M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 571,142 | 72,245 | -498,897 | $6.71M | $825.8K | 0.09% | -$5.89M |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 133,333 | 124,119 | -9,214 | $26.9K | $41.0K | 0.00% | +$14.0K |
| Aura Biosciences, Inc.(AURA) | 584,849 | 0 | -584,849 | $3.61M | $0 | — | -$3.61M |
| Avadel Pharmaceuticals Plc | 675,504 | 0 | -675,504 | $10.31M | $0 | — | -$10.31M |
| Bolt Biotherapeutics Inc | 48,830 | 0 | -48,830 | $259.8K | $0 | — | -$259.8K |
| LENZ Therapeutics, Inc.(LENZ) | 343,012 | 0 | -343,012 | $15.98M | $0 | — | -$15.98M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 30,285 | 0 | -30,285 | $3.06M | $0 | — | -$3.06M |
| Surrozen, Inc.(SRZN) | 241,400 | 0 | -241,400 | $3.11M | $0 | — | -$3.11M |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 99,999 | 0 | -99,999 | $1.8K | $0 | — | -$1.8K |
| Sutro Biopharma, Inc.(STRO) | 2,196,814 | 0 | -2,196,814 | $1.91M | $0 | — | -$1.91M |
| Terns Pharmaceuticals Inc | 135,573 | 0 | -135,573 | $1.02M | $0 | — | -$1.02M |
| Zymeworks Inc.(ZYME) | 207,901 | 0 | -207,901 | $3.55M | $0 | — | -$3.55M |